Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 74
Selected: 0
NCT IDTitle
NCT03064113Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT02705755TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
NCT00674817An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT00550225Succinate Salt Version of GSK961081 for Healthy Volunteers
NCT03750565Multiple Dose Ethnobridging PK Study in Healthy Subjects
NCT02903095Single Ascending Dose Study of TD-1439 in Healthy Subjects
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)
NCT02753855Pharmacokinetics of Telavancin in Normal and Obese Subjects
NCT05091723TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
NCT04315558Revefenacin in Acute Respiratory Insufficiency in COPD
NCT03635112Efficacy and Safety of TD-1473 in Crohn's Disease
NCT04044339Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT02581592Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
NCT017044047 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
NCT03432793Drug-Drug Interaction (DDI) Study for TD-9855
NCT01568411A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211
NCT03555617Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
NCT01459926A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation
NCT00391820Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
NCT01949103TD-1607 MAD Study in Healthy Subjects
NCT02663089A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
NCT02022306TD-6450 SAD and MAD in Healthy Subjects
NCT01953081A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
NCT01655771TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
NCT02109172A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT03103412TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
NCT02518139A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT02820311Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
NCT01467726Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
NCT02392208Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
NCT01791049TD-1607 SAD Study in Healthy Subjects
NCT04095793Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT01321879Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
NCT01040637A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation
NCT00887406Study of GSK961081 in Healthy Volunteer Subjects
NCT01401985A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
NCT04681079Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT02954263Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects
NCT03829657Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT04402866TD-0903 for ALI Associated With COVID-19
NCT03750552Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT04688632Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
NCT04350736First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
NCT00687700A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
NCT01458340A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT02116543TD-6450 MAD Study in HCV Infected Subjects
NCT04587713Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
NCT02267525The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT03758443Efficacy & Safety of TD-1473 in Ulcerative Colitis